Overactive Bladder clinical trials
39 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- TReating Incontinence for Underlying Mental and Physical Health
- Add-On ZIDA Sock Therapy for Overactive Bladder
- Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- Zinc Supplementation With Botulinum Toxin for Overactive Bladder
- Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
- Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
- Yoga for Treatment of Overactive Bladder in Pediatric Patients
- APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
- A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
- Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
- Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation
- At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
- PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
- Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
- Percutaneous Nerve Evaluation Trial Time
- Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
- Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients
- Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Antibiotic Usage Prior to OnabotulinumtoxinA Injection
- Bladder Botox UTI Antibiotic Prophylaxis
- Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
- NXT Post-Market Clinical Follow-up
- Noninvasive Ultrasound Assessment of Detrusor Dysfunction
- Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
- Ambulatory Long Length URodynamics Evaluation
- Pelvic Health Electrically Evoked Recording (PEER) 2 Study
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
- Tensi+ for Treating Overactive Bladder
- A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections
- Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection
- Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms
- Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy
- Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease
- Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy
- Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
- Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections
- Migraine Medication Effects on Urinary Symptoms
- Optimal Injection Interval for Intra-Detrusor Botulinum Toxin
- Trial for Reliability of Urodynamics SysTem
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Overactive Bladder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.